Relay Therapeutics (RLAY) Change in Receivables (2021 - 2023)
Relay Therapeutics (RLAY) reported Change in Receivables of -$211000.0 for Q4 2023, down 424.62% year-over-year from $65000.0 in Q4 2022, and down 258.65% quarter-over-quarter from $133000.0 in Q3 2023.
Relay Therapeutics (RLAY) Change in Receivables (2021 - 2023) Analysis & Trends
Relay Therapeutics (RLAY) has 3 years of Change in Receivables data on file, last reported at -$211000.0 in Q4 2023.
- Change in Receivables for Q4 2023 came in at -$211000.0, down 424.62% year-over-year; the trailing twelve-month figure through Dec 2023 was -$306000.0 (down 215.46% YoY), and the FY2023 annual result was -$306000.0, down 215.46% from the prior year.
- Change in Receivables fell to -$211000.0 in Q4 2023 per RLAY's latest filing, from $133000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $525000.0 in Q3 2021 and troughed at -$75.0 million in Q1 2021.
- A 3-year average of -$6.3 million and a median of -$33500.0 in 2022 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 382.98% in 2023 and fell as far as 1194.74% in 2023.
- A 3-year view of Change in Receivables shows it stood at -$401000.0 in 2021, then soared by 116.21% to $65000.0 in 2022, then slumped by 424.62% to -$211000.0 in 2023.
- Business Quant data shows RLAY's Change in Receivables at -$211000.0 in Q4 2023, $133000.0 in Q3 2023, and -$208000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2023 | -211,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | -208,000.00 |
| Jun 30, 2023 | -208,000.00 |
| Mar 31, 2023 | -20,000.00 |
| Mar 31, 2023 | -20,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | -47,000.00 |
| Sep 30, 2022 | -47,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | -134,000.00 |
| Mar 31, 2022 | -134,000.00 |
| Dec 31, 2021 | -401,000.00 |
| Dec 31, 2021 | -401,000.00 |
| Sep 30, 2021 | 525,000.00 |
| Sep 30, 2021 | 525,000.00 |